A/S Femern Landanlæg
6.9.2024 11:07:45 CEST | Globenewswire | Press release
Notice of Extraordinary General Meeting
Notice is hereby given that the extraordinary general meeting of A/S Femern Landanlæg, CVR no. 32567967, will be held on 23 September at 9.00 am at the company’s premises, Vester Søgade 10, 5th floor, DK-1601 Copenhagen V.
The purpose of the extraordinary general meeting is to elect a new member to the Board of Directors, including a new Vice-Chairman of the Board of Directors.
Items on the agenda are:
- Election of chairman of the meeting
- Proposal to elect new member of the Board of Directors, including as new Vice-Chairman of the Board of Directors
Below are the complete resolutions with accompanying remarks.
Re. item 1
It is proposed that Group General Counsel, lawyer Charlotte Linde be elected chairman of the meeting.
Re. item 2
Signe Thustrup Kreiner resigns as member of the Board of Directors, including as Vice-Chairman of the Board of Directors, on 9 September 2024.
It is proposed to elect Natacha Krogager Carlsson as new member of the Board of Directors, including as new Vice-Chairman of the Board of Directors. For background information on the candidate, please consult the CV attached to this notice (Exhibit 1).
Board of Directors
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Newcap Holdings29.3.2026 12:19:20 CEST | Pressemeddelelse
NewCap Holding A/S har indgået en aftale, betinget af underskrivelse af endelige aftaledokumenter m.v., om erhvervelse af dansk selskab indenfor compliance og risikostyringsservices – Intern viden
Novartis Pharma AG29.3.2026 07:15:00 CEST | Press release
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%
Biogen Inc.28.3.2026 20:00:00 CET | Press release
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
MoonLake Immunotherapeutics AG28.3.2026 20:00:00 CET | Press release
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
Sanofi Winthrop Industrie28.3.2026 16:00:00 CET | Press release
Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
